Related Experiment Video
Updated: Jan 20, 2026

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
Published on: June 10, 2025
Prognostic values of novel biomarkers in patients with AL amyloidosis
Darae Kim1, Ga Yeon Lee1, Jin-Oh Choi1
1Division of Cardiology, Department of Medicine, Heart Vascular Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Insights
Novel biomarkers soluble suppression of tumorigenicity 2 (sST2) and growth differentiation factor 15 (GDF15) improve prognosis prediction in light-chain amyloidosis (AL). These markers offer additive value beyond current standards, enhancing risk stratification for AL patients.
Area of Science:
- Cardiology
- Oncology
- Biomarker Discovery
Background:
- Cardiac involvement is a key prognostic factor in light-chain amyloidosis (AL).
- Current staging (revised Mayo) uses NT-proBNP and TnT, but novel biomarkers' roles are unclear.
- Investigating new biomarkers can refine prognostic accuracy in AL.
Purpose of the Study:
- To evaluate the additive prognostic value of novel biomarkers (sST2, GDF15, OPN) in AL amyloidosis.
- To determine if these markers improve prediction of overall mortality beyond established markers.
- To assess their utility in stratifying risk, especially in advanced disease stages.
Main Methods:
- Quantified sST2, GDF15, and OPN levels in 73 AL patients at diagnosis.
- Utilized ROC analysis to assess predictive performance for survival.
- Correlated biomarker levels with established markers (NT-proBNP, TnT) and clinical parameters.
Main Results:
- sST2 and GDF15 demonstrated significant predictive performance for one-year and overall survival.
- Elevated sST2 and GDF15 provided incremental prognostic value beyond NT-proBNP and TnT.
- Higher scores based on sST2/GDF15 predicted worse outcomes, even within advanced Mayo stages.
Conclusions:
- sST2 and GDF15 are valuable prognostic biomarkers in AL amyloidosis.
- These novel markers offer additive predictive power, enhancing risk stratification for AL patients.
- They improve prognostication, particularly in patients with advanced disease stages.
Abstract:
As cardiac involvement is the most important prognostic marker in light-chain amyloidosis (AL), revised Mayo staging for AL incorporated N-terminal pro-brain natriuretic peptide (NTproBNP) and troponin T (TnT). However, prognostic value of novel biomarkers, such as soluble suppression of tumorigenicity 2 (sST2), growth differentiation factor 15 (GDF15), or osteopontin (OPN) is unknown in AL amyloidosis. We aimed to investigate additive predictive effects of novel biomarkers for overall mortality rates of AL amyloidosis patients. Levels of sST2, GDF15, and OPN were quantified at diagnosis in a total of 73 AL amyloidosis patients at Samsung Medical Center from 2010 to 2016. The median follow-up duration of the censored cases was 18.0 (12.4-28.1) months. A total of 25 deaths occurred during the follow-up period. Two novel biomarkers, sST2 and GDF-15 showed satisfactory predictive performances for both one-year and overall survival from ROC analysis. Best cut-off values for predicting one-year mortality were selected. Elevated sST2 and GDF-15 levels showed significant incremental prognostic values in addition to NT-ProBNP and TnT for overall mortality. Patients were assigned 1 point for elevated sST2 or GDF-15. The mean values of NT-proBNP, TnT, mean LV wall thickness, and septal e' velocity differed significantly according to the scores. Patients with higher scores showed significantly worse prognosis even in patients with advanced revised Mayo staging. Two novel biomarkers, sST2 and GDF-15, showed satisfactory prognostic value for overall survival of AL amyloidosis patients. Furthermore, sST2 and GDF-15 showed additive incremental values over conventional biomarkers and further discriminated prognosis of patients in advanced stages.
Related Concept Videos
Biodiversity and Human Values
Professional Values
The values that are the foundation of the nursing profession are altruism, autonomy, human dignity, and social justice.
First, altruism refers to the concern for the welfare and well-being of others without personal...
Critical Values
z Scores and Unusual Values
This score indicates how far a value is from the mean in terms of standard deviation. For example, if a data value has a z score of +1, the researcher can infer that the particular data value is one standard deviation above the mean. If another data...
Absolute and Local Extreme Values
Finding Critical Values for Chi-Square

